Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
1 competitor in Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
View Full LandscapeTarget Indication
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Clinical Trial
NCT07241416Last updated: 1/8/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
KNEE OSTEOARTHRITIS
Advanced Solid Tumor
Carcinoma, Hepatocellular
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy